Keywords: Multiple Myeloma Redarch Consortium, Accelerating clinical trials, Onxy, Carfilzomib

Multiple Myeloma Research Consortium claims it accelerates clinical trial process

Article | 08 December 2010

The Multiple Myeloma Research Consortium (MMRC) says that clinical trials conducted within the Consortium open 60% faster than the industry benchmark ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Onyx Pharmaceuticals

Go to company listing

Related Drugs

carfilzomib

Go to drug listing